Combo Products GMP Guidance Fills In Gaps On Drug-Delivery Device Compliance
This article was originally published in The Gray Sheet
Executive Summary
FDA has delivered a draft current good manufacturing practices guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device, drug/biological and drug/device/biological products.
You may also be interested in...
FDA Issues Final Guideline On Combination Product GMPs
The document provides real-world tips demonstrating how the agency expects manufacturers to apply GMP rules to combination products. It's linked to a 2013 rule on the subject.
2016 Will Be A Big Year For Combo Product Reform, FDA Says
Having earlier signaled its plan to propose a new statutory pathway for combination products by the end of 2016, the agency is now working on a bevy of process changes, guidance documents and rules to enhance premarket and postmarket regulation of combination products in the years ahead.
2016 Will Be A Big Year For Combo Product Reform, FDA Says
The agency has already signaled its plan to propose a new statutory pathway for combination products by the end of next year. In the meantime, it's working on a bevy of process changes, guidance documents and rules to enhance premarket and postmarket regulation of combination products in the years ahead. Office of Combination Products officials John Weiner and Thinh Nguyen weigh in.